Resilience-Building for Advance Care Planning

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT07428278
Status
Recruiting

Conditions

  • Advanced Cancer
  • End of Life

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • ROCKS — BEHAVIORAL
    The intervention will be provided to participants to strengthen optimism, communication skills, knowledge, and self-efficacy to support patients and family caregivers in engaging in advance care planning discussions.
  • Usual Care — BEHAVIORAL
    An advance directive called Five Wishes will be provided to participants to increase their knowledge about advance care planning.

Study Details

The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.

Key Dates

Start date
May 28, 2026
Status verified
Feb 2026
Primary completion
May 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
152 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: ROCKS
    Participants assigned to this arm will receive a web-based resilience-building intervention.
  • Active Comparator: Usual Care
    Participants assigned to this arm will receive an advance directive called Five Wishes.

Primary Outcome Measure

Completion of advance directives [ Time Frame: Week 8 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Illinois ChicagoChicagoIllinois60607
Li-Ting H. Longcoy
312-996-3024

Find similar trials in Chicago, IL

Related Studies